Subsequently, to investigate whether survivin expression promoted drug resistance, we analyzed drug resistance AML cell line TS3 (isolated from CD34+ cells), established from a patient who relapsed despite treatment with chemotherapy, and used for further experiments. Here, BIRC5 is linked to acute myeloid leukemia.